SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-06-008437
Filing Date
2006-02-13
Accepted
2006-02-13 17:08:34
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 BENEFICIAL OWNERSHIP OF 5% OR MORE a06-4579_30sc13ga.htm SC 13G/A 239387
  Complete submission text file 0001104659-06-008437.txt   241507
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47771 | Film No.: 06604665
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

IRS No.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A